Bio Pharma Dive

MARCH 30, 2021

Two drugs developed by Wave Life Sciences didn't appear to have an effect on disease-causing proteins, another setback for Huntington's research after disappointing results last week from Roche and Ionis.

Life Science 313

Life Science Drugs Protein Trials 313

Bio Pharma Dive

NOVEMBER 16, 2020

A new industry consortium is lining up stakeholders to work together to address long-standing pain points that disrupt clinical trials.

Clinical Trials 176

Clinical Trials Clinical Trials Life Science Trials 176

Cloudbyz

NOVEMBER 22, 2024

Cloudbyz’s inclusion in this respected benchmark report underscores its dedication to advancing clinical trial management through robust, innovative technology designed to optimize data collection, ensure regulatory compliance, and streamline trial processes. “We

Life Science 52

Life Science Clinical Trials Clinical Trials Compliance 52

Bio Pharma Dive

JULY 3, 2023

What is the GDPR and why does it matter to your life sciences company. iliomad Health Data can help you maintain GDPR compliance.

Life Science 246

Life Science Compliance Trials 246

XTalks

DECEMBER 19, 2024

Despite advancements in neuroscience and psychiatry, clinical trials for mental health conditions such as major depressive disorder (MDD), schizophrenia, bipolar disorder and generalized anxiety disorder face unique challenges. One of the main challenges lies in defining and selecting appropriate trial populations.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Research 97

XTalks

JANUARY 16, 2025

BlueRock Therapeutics, a subsidiary of Bayer AG, is making waves in the treatment of Parkinsons disease by advancing its investigational cell therapy, bemdaneprocel, to a Phase III clinical trial. The clinical advancement follows a thorough review of Phase I trial data under the FDAs Regenerative Medicine Advanced Therapy (RMAT) designation.

Trials 104

Trials Clinical Trials Clinical Trials Gene Therapy 104

Pharmaceutical Technology

JULY 28, 2022

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Industry clusters.

Life Science 130

Life Science Marketing Production Research 130

Cloudbyz

MAY 17, 2024

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. These systems must undergo thorough conformity assessments to verify their compliance with safety, transparency, and accountability standards, thereby boosting the reliability and integrity of clinical trial data.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

Pharmaceutical Technology

DECEMBER 14, 2022

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. On completion of the first-in-patient clinical trial by Wave, GSK will be in charge of the development and marketing works.

Life Science 162

Life Science Development Gene Therapy Genetics 162

XTalks

APRIL 8, 2025

Global rare disease clinical trials face unique challenges due to small patient populations, complex logistics, diverse regulatory environments and cultural differences. Clinical Trial Manager/Sr. These measures enhance recruitment, retention and overall trial success.

Clinical Trials 88

Clinical Trials Clinical Trials Trials Gene Therapy 88

Pharmaceutical Technology

JUNE 2, 2023

Anavex Life Sciences has secured new US intellectual property compositions patent for its ANAVEX 2-73 (blarcamesine). The patent number 11,661,405 has been issued by the US Patent and Trademark Office (USPTO) and is expected to remain effective until October 2036.

Life Science 130

Life Science Clinical Trials Clinical Trials Trials 130

ACRP blog

OCTOBER 10, 2024

The same is true in life sciences. As the technology develops, however, it will offer more opportunities to expedite drug discovery processes, streamline clinical trials, and speed up regulatory approvals. A Blueprint for Adoption in Clinical Trials That’s where large integrated site organizations come in.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Life Science 69

XTalks

DECEMBER 10, 2024

The surge in MASH cases stresses the need for early diagnosis, timely intervention and precise, reliable methodologies in clinical trials to evaluate new therapies effectively. Nicola Owen, PhD, MBBS, Medical Directorthey shared insights into the operational and medical strategies that support the design and conduct of MASH clinical trials.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

NOVEMBER 15, 2024

Syros Pharmaceuticals announced that its cancer drug tamibarotene failed to meet its primary endpoint in the SELECT-MDS-1 Phase III trial. The placebo-controlled SELECT-MDS-1 trial involved 190 patients with complete response rate (CRR) being the study’s primary endpoint. percent and 18.8

Trials 105

Trials HR Immune Response FDA Approval 105

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 9, 2024

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 185

Trials Life Science Clinical Trials Clinical Trials 185

XTalks

MARCH 14, 2025

mg), underperformed in its latest clinical trial, leading to a dip in the companys share price. In response to the trial outcomes, Novos shares declined by approximately 8% this week. Novo shared the latest data from the Phase III REDEFINE 2 trial evaluating the drug in overweight or obese patients with type 2 diabetes.

Trials 89

Trials Drugs Clinical Trials Clinical Trials 89

XTalks

DECEMBER 10, 2024

In the trial, platelet response, defined as achieving at least 50,000 platelets per microliter or doubling baseline counts, was seen in 65 percent of patients on rilzabrutinib, compared to 33 percent on placebo. Participants received either rilzabrutinib or placebo for 24 weeks, followed by an open-label extension.

Trials 104

Trials Protein Clinical Development Drugs 104

Pharmaceutical Technology

JUNE 20, 2023

Most of us have heard of ChatGPT and AI but where and how do they fit into the life sciences ecosystem? AI-powered solutions in healthcare While the impact of AI will be far-reaching, its pattern-matching abilities and processing speed means AI has the potential to revolutionise the field of life sciences and medicine, in particular.

Life Science 130

Life Science Clinical Trials Clinical Trials Regulation 130

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

OCTOBER 31, 2024

This includes new Phase III trial data for Kerendia (finerenone) in patients with heart failure that was presented recently at this year’s European Society of Cardiology (ESC) Congress 2024. Tune into the episode to hear more about the latest trial data for finerenone in heart failure and the landscape of heart failure research.

Life Science 52

Life Science Cardiology Trials Development 52

Pharmaceutical Technology

MAY 24, 2023

By Luisa Sterkel & Joana Loureiro , Tenthpin Consultants The promise and potential of cell and gene therapies (CGT) has emerged in the recent past and currently over 1.500 CGT are registered for clinical trials holding great hope for the treatment of challenging and uncurable diseases.

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

XTalks

NOVEMBER 1, 2023

Dr. Manson Brown’s Clinical Development and Scientific Innovation team are responsible for global clinical trial development strategy for the Aesthetic Medicine portfolio, covering pharmaceuticals and device. Dr. Brown is co-chair of the Aesthetics Pharmaceutical Governance Board at AbbVie and is the co-founder of the Science of Aging.

Life Science 105

Life Science Clinical Trials Clinical Trials Clinical Development 105

XTalks

FEBRUARY 14, 2024

OncoImmune was founded in 2000 based on the scientific discoveries of the company’s founders who moved their lead product from a basic concept into clinical trials for multiple indications. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 119

Life Science DNA Production Clinical Trials 119

Pharmaceutical Technology

MARCH 2, 2023

The growth in sales was driven by all regions and business sectors, particularly Life Science. to €10.38bn in its Life Science business during the year. The EBITDA pre of Life Science grew by 14.4% Merck has reported an increase in group net sales by 12.9% to €22.23bn in fiscal 2022 against €19.68bn in 2021.

Sales 245

Sales Life Science Licensing Licensing 245

Pharmaceutical Technology

JULY 8, 2022

VDRs may be used for asset sales, audit tenders, bankruptcies, due diligence processes, mergers & acquisitions, public and private debt and equity capital raising, clinical trials, and organisational restructuring. The post Virtual data room use for life sciences M&A deals rising appeared first on Pharmaceutical Technology.

Life Science 130

Life Science Regulation Clinical Trials Clinical Trials 130

XTalks

DECEMBER 26, 2024

Menarini Group has announced positive topline data from the Phase III BROADWAY and TANDEM clinical trials, evaluating obicetrapib and the fixed-dose combination of obicetrapib with ezetimibe. Meanwhile, the TANDEM trial evaluated a fixed-dose combination of obicetrapib with 10 mg ezetimibe in a similar patient population.

Trials 52

Trials Life Science Clinical Trials Clinical Trials 52

XTalks

SEPTEMBER 13, 2023

The drug is the only natural THC-based investigational drug undergoing FDA trials. Ram and Claudia spoke about the compound, including clinical data from the ongoing trials evaluating it. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 110

Life Science Trials Compliance Engineer 110

XTalks

APRIL 3, 2024

The candidate is currently being evaluated in Phase II and Phase III clinical trials. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. To hear more about ProKidney’s cell therapy for chronic kidney disease, including developmental, manufacturing and regulatory considerations, tune into the episode.

Life Science 105

Life Science Clinical Trials Clinical Trials Manufacturing 105

XTalks

NOVEMBER 19, 2024

In clinical research, diversity is more than a prerequisite for a successful drug — it’s a critical component that enhances the validity and applicability of clinical trial outcomes. Diversity Action Plans have now moved from being a “nice-to-have” to a “must-have” in clinical trial designs. Baker McDowell, Head of Regulatory Strategy.

Clinical Trials 64

Clinical Trials Clinical Trials Trials Production 64

Pharmaceutical Technology

JUNE 6, 2023

Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management. It decreased vitamin A dimerization by more than 80% and prevented blindness in a genetic animal model of the disease in preclinical trials.

Genetics 279

Genetics Life Science Trials Clinical Development 279

XTalks

FEBRUARY 4, 2025

Current Share Price: The announcement follows a $115 million Series D financing in December 2024, co-led by Frazier Life Sciences and Deep Track Capital, with participation from Janus Henderson Investors and Logos Capital. The Phase I trial showed promising safety and pharmacokinetics. for an upfront payment of $150 million.

Clinical Trials 66

Clinical Trials Clinical Trials Trials Genetics 66

XTalks

OCTOBER 23, 2024

In this episode, Vera spoke with Morgan Hanger, Executive Director of the Clinical Trials Transformation Initiative (CTTI). CTTI is a public-private partnership dedicated to improving the quality and efficiency of clinical trials, with an ambitious “Transforming Trials 2030” vision.

Clinical Research 64

Clinical Research Clinical Trials Clinical Trials Life Science 64

Camargo

NOVEMBER 22, 2021

This year, Camargo is highlighting one of our own, Manager of Life Science Solutions Andrea Miller, who cared for her husband Tom throughout his battle with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. We wanted to participate in a clinical trial. You aren’t thinking about treatments and trials.

Clinical Trials 198

Clinical Trials Clinical Trials Trials Research 198

XTalks

APRIL 15, 2025

The landscape of rare disease clinical trials has seen significant transformation over the past decade. However, many challenges remain in ensuring patient access, optimizing trial design and leveraging technological advancements to improve outcomes. Improving diversity in clinical trials has become a key priority in recent years.

Trials 52

Trials Clinical Trials Clinical Trials Gene Therapy 52

XTalks

MARCH 27, 2024

He is responsible for evidence portfolio across two therapeutic indications, chronic kidney disease and heart failure, encompassing seven active trials and studies and more than 3,000 US patients. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 105

Life Science Development Trials 105

XTalks

MARCH 11, 2025

XTALKS WEBINAR: Redefining Womens Cancer Care: Delivering Smarter, Safer Clinical Trials Live and On-Demand: Thursday, April 10, 2025, at 11am EDT (4pm BST/UK) Register for this free webinar to explore innovative approaches to enhancing clinical trials for breast and gynecological cancers.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

XTalks

APRIL 3, 2025

Eli Lilly shared new Phase II trial data showing that its experimental siRNA therapy, lepodisiran, leads to reductions in levels of lipoprotein(a) (Lp(a)) a genetically inherited risk factor for heart disease in adults with elevated levels of the marker. The 400 mg dose was the highest lepodisiran dose in the trial.

Trials 59

Trials Clinical Trials Clinical Trials Genetics 59